Hot Penny Stocks To Add to Your Watchlist Right Now dailyherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyherald.com Daily Mail and Mail on Sunday newspapers.
NA Proactive news snapshot: PharmaDrug, Kintara Therapeutics, QC Copper and Gold, New Pacific Metals UPDATE …
A glance at some of the day s highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive
PharmaDrug Inc (CSE:BUZZ) (OTCPINK:LMLLF) said it has entered into a supply agreement with a Eurozone cannabis extractor to produce medical-grade THC oil for sale under PharmaDrug s own brand. The company said it expects to receive the THC product and begin selling it in Germany by September. “We are extremely excited to sign this agreement to finally launch medical cannabis in Germany under our own brand. The company is making several movers to significantly increase its presence and volumes in the German medical cannabis market,” PharmaDrug CEO Daniel Cohen said in a statement.
Kintara Therapeutics ends fiscal 3Q with cash and cash equivalents of about $15.7M
The capital runway is expected to be sufficient to fund the company s planned operations to the second quarter of calendar year 2022 Kintara achieved the healthy cash stockpile primarily due to the exercise of warrants as well as operational and resource synergies realized through the Adgero Biopharmaceuticals merger in August 2020
Kintara Therapeutics Inc (NASDAQ:KTRA), which is focused on the development of new solid tumor cancer therapies, said it closed its fiscal third quarter with cash and cash equivalents of about $15.7 million.
That capital, the company said, is expected to be sufficient to fund its planned operations to the second quarter of calendar year 2022.